Načítá se...
Gain-of-function mutant p53 in cancer progression and therapy
p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite for cancer development. The p53 gene is the most frequently mutated gene in human cancers; p53 mutations occur in >50% of all human cancers and in almost every type of human cancers. Most of p53 mutations in canc...
Uloženo v:
| Vydáno v: | J Mol Cell Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749743/ https://ncbi.nlm.nih.gov/pubmed/32722796 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjaa040 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|